Browse By: Country ι Category ι Latest Reports ι Tag
Home  »  Global Markets Direct

Global Markets Direct Market Research Reports

Global Markets Direct is a leading provider of global business intelligence and market analysis. The company publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. With a large dedicated research and analysis capability, Global Markets Direct employs rigorous primary and secondary research techniques in developing unique data sets and research materials.

At the heart of Global Markets Direct are unique databases, updated live, covering millions of rows of key information for the studied industry at a global level.

Glucose-Dependent Insulinotropic Receptor (G-Protein Coupled Receptor 119 or GPR119) - Pipeline Review, H1 2016
Summary Global Markets Direct’s, ‘Glucose-Dependent Insulinotropic Receptor (G-Protein Coupled Receptor 119 or GPR119) - Pipeline Review, H1 2016’, provides in depth analysis on Glucose-Dependent Insulinotropic Receptor (G-Protein Coupled Receptor 119 or GPR119) targeted pipeline therapeutics. The report provides comprehensive information on the Glucose-Dependent Insulinotropic Receptor (G-Protein Coupled Receptor 119 or GPR119), targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provi
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $3500
Free Fatty Acid Receptor 1 (G-Protein Coupled Receptor 40 or FFAR1) - Pipeline Review, H1 2016
Summary Global Markets Direct’s, ‘Free Fatty Acid Receptor 1 (G-Protein Coupled Receptor 40 or FFAR1) - Pipeline Review, H1 2016’, provides in depth analysis on Free Fatty Acid Receptor 1 (G-Protein Coupled Receptor 40 or FFAR1) targeted pipeline therapeutics. The report provides comprehensive information on the Free Fatty Acid Receptor 1 (G-Protein Coupled Receptor 40 or FFAR1), targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in Free Fat
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $3500
KiSS-1 Receptor (G-Protein Coupled Receptor 54 or G-Protein Coupled Receptor OT7T175 or hOT7T175 or Hypogonadotropin-1 or Kisspeptins Receptor or Metastin Receptor or KISS1R or GPR54) - Pipeline Review, H1 2016
Summary Global Markets Direct’s, ‘KiSS-1 Receptor (G-Protein Coupled Receptor 54 or G-Protein Coupled Receptor OT7T175 or hOT7T175 or Hypogonadotropin-1 or Kisspeptins Receptor or Metastin Receptor or KISS1R or GPR54) - Pipeline Review, H1 2016’, provides in depth analysis on KiSS-1 Receptor (G-Protein Coupled Receptor 54 or G-Protein Coupled Receptor OT7T175 or hOT7T175 or Hypogonadotropin-1 or Kisspeptins Receptor or Metastin Receptor or KISS1R or GPR54) targeted pipeline therapeutics. The report provides comprehensive information on the KiSS-1 Receptor (G-Protein Coupled Receptor 54 or G-Protein Coupled Receptor OT7T175 or hOT7T175 or Hypogonadotropin-1 or Kisspeptins Receptor or Metastin Receptor or KISS1R or GPR54), targeted therapeutics, complete with analysis by indicatio
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $3500
Gastric Inhibitory Polypeptide Receptor (GIP-R or Glucose-Dependent Insulinotropic Polypeptide Receptor or GIPR) - Pipeline Review, H1 2016
Summary Global Markets Direct’s, ‘Gastric Inhibitory Polypeptide Receptor (GIP-R or Glucose-Dependent Insulinotropic Polypeptide Receptor or GIPR) - Pipeline Review, H1 2016’, provides in depth analysis on Gastric Inhibitory Polypeptide Receptor (GIP-R or Glucose-Dependent Insulinotropic Polypeptide Receptor or GIPR) targeted pipeline therapeutics. The report provides comprehensive information on the Gastric Inhibitory Polypeptide Receptor (GIP-R or Glucose-Dependent Insulinotropic Polypeptide Receptor or GIPR), targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and de
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $3500
Nociceptin Receptor (Kappa-Type 3 Opioid Receptor or KOR-3 or Orphanin FQ Receptor or OPRL1 or OOR or ORL1) - Pipeline Review, H1 2016
Summary Global Markets Direct’s, ‘Nociceptin Receptor (Kappa-Type 3 Opioid Receptor or KOR-3 or Orphanin FQ Receptor or OPRL1 or OOR or ORL1) - Pipeline Review, H1 2016’, provides in depth analysis on Nociceptin Receptor (Kappa-Type 3 Opioid Receptor or KOR-3 or Orphanin FQ Receptor or OPRL1 or OOR or ORL1) targeted pipeline therapeutics. The report provides comprehensive information on the Nociceptin Receptor (Kappa-Type 3 Opioid Receptor or KOR-3 or Orphanin FQ Receptor or OPRL1 or OOR or ORL1), targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development histo
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $3500
Delta-Like Ligand 4 (DLL4 or Drosophila Delta Homolog 4) - Pipeline Review, H1 2016
Summary Global Markets Direct’s, ‘Delta-Like Ligand 4 (DLL4 or Drosophila Delta Homolog 4) - Pipeline Review, H1 2016’, provides in depth analysis on Delta-Like Ligand 4 (DLL4 or Drosophila Delta Homolog 4) targeted pipeline therapeutics. The report provides comprehensive information on the Delta-Like Ligand 4 (DLL4 or Drosophila Delta Homolog 4) , targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in Delta-Like Ligand 4 (DLL4 or Drosophila
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $3500
Ache Laboratorios Farmaceuticos S/A - Product Pipeline Review - 2016
Summary Global Markets Direct’s, ‘Ache Laboratorios Farmaceuticos S/A - Product Pipeline Review - 2016’, provides an overview of the Ache Laboratorios Farmaceuticos S/A’s pharmaceutical research and development focus. The report provides comprehensive information on the therapeutics under development by Ache Laboratorios Farmaceuticos S/A, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects. Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indic
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $1500
Anacor Pharmaceuticals, Inc. - Product Pipeline Review - 2016
Summary Global Markets Direct’s, ‘Anacor Pharmaceuticals, Inc. - Product Pipeline Review - 2016’, provides an overview of the Anacor Pharmaceuticals, Inc.’s pharmaceutical research and development focus. The report provides comprehensive information on the therapeutics under development by Anacor Pharmaceuticals, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects. Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $1500
Compugen Ltd. - Product Pipeline Review - 2016
Summary Global Markets Direct’s, ‘Compugen Ltd. - Product Pipeline Review - 2016’, provides an overview of the Compugen Ltd.’s pharmaceutical research and development focus. The report provides comprehensive information on the therapeutics under development by Compugen Ltd., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects. Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced fro
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $1500
Ionis Pharmaceuticals, Inc. - Product Pipeline Review - 2016
Summary Global Markets Direct’s, ‘Ionis Pharmaceuticals, Inc. - Product Pipeline Review - 2016’, provides an overview of the Ionis Pharmaceuticals, Inc.’s pharmaceutical research and development focus. The report provides comprehensive information on the therapeutics under development by Ionis Pharmaceuticals, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects. Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is bu
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $1500
Nektar Therapeutics - Product Pipeline Review - 2016
Summary Global Markets Direct’s, ‘Nektar Therapeutics - Product Pipeline Review - 2016’, provides an overview of the Nektar Therapeutics’s pharmaceutical research and development focus. The report provides comprehensive information on the therapeutics under development by Nektar Therapeutics, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects. Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and infor
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $1500
NewLink Genetics Corporation - Product Pipeline Review - 2016
Summary Global Markets Direct’s, ‘NewLink Genetics Corporation - Product Pipeline Review - 2016’, provides an overview of the NewLink Genetics Corporation’s pharmaceutical research and development focus. The report provides comprehensive information on the therapeutics under development by NewLink Genetics Corporation, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects. Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $1500
OPKO Health, Inc. - Product Pipeline Review - 2016
Summary Global Markets Direct’s, ‘OPKO Health, Inc. - Product Pipeline Review - 2016’, provides an overview of the OPKO Health, Inc.’s pharmaceutical research and development focus. The report provides comprehensive information on the therapeutics under development by OPKO Health, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects. Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $1500
Viamet Pharmaceuticals, Inc. - Product Pipeline Review - 2016
Summary Global Markets Direct’s, ‘Viamet Pharmaceuticals, Inc. - Product Pipeline Review - 2016’, provides an overview of the Viamet Pharmaceuticals, Inc.’s pharmaceutical research and development focus. The report provides comprehensive information on the therapeutics under development by Viamet Pharmaceuticals, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects. Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $1500
Ulcerative Colitis - Pipeline Review, H1 2016
Summary Global Markets Direct’s, ‘Ulcerative Colitis - Pipeline Review, H1 2016’, provides an overview of the Ulcerative Colitis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Ulcerative Colitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Ulcerative Colitis and features dormant and discontinued projects. Global Markets Direct’s report features investigational dr
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $2000
Type 2 Diabetes - Pipeline Review, H1 2016
Summary Global Markets Direct’s, ‘Type 2 Diabetes - Pipeline Review, H1 2016’, provides an overview of the Type 2 Diabetes pipeline landscape. The report provides comprehensive information on the therapeutics under development for Type 2 Diabetes, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Type 2 Diabetes and features dormant and discontinued projects. Global Markets Direct’s report features investigational drugs from acr
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $2500
Asthma - Pipeline Review, H1 2016
Summary Global Markets Direct’s, ‘Asthma - Pipeline Review, H1 2016’, provides an overview of the Asthma pipeline landscape. The report provides comprehensive information on the therapeutics under development for Asthma, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Asthma and features dormant and discontinued projects. Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy a
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $2500
Head and neck Cancer - Pipeline Review, H1 2016
Summary Global Markets Direct’s, ‘Head And Neck Cancer - Pipeline Review, H1 2016’, provides an overview of the Head And Neck Cancer pipeline landscape. The report provides comprehensive information on the therapeutics under development for Head And Neck Cancer, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Head And Neck Cancer and features dormant and discontinued projects. Global Markets Direct’s report features investigat
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $2500
Gastric Cancer - Pipeline Review, H1 2016
Summary Global Markets Direct’s, ‘Gastric Cancer - Pipeline Review, H1 2016’, provides an overview of the Gastric Cancer pipeline landscape. The report provides comprehensive information on the therapeutics under development for Gastric Cancer, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Gastric Cancer and features dormant and discontinued projects. Global Markets Direct’s report features investigational drugs from across
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $2000
Fallopian Tube Cancer - Pipeline Review, H1 2016
Summary Global Markets Direct’s, ‘Fallopian Tube Cancer - Pipeline Review, H1 2016’, provides an overview of the Fallopian Tube Cancer pipeline landscape. The report provides comprehensive information on the therapeutics under development for Fallopian Tube Cancer, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Fallopian Tube Cancer and features dormant and discontinued projects. Global Markets Direct’s report features invest
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $2000
Idiopathic Pulmonary Fibrosis - Pipeline Review, H1 2016
Summary Global Markets Direct’s, ‘Idiopathic Pulmonary Fibrosis - Pipeline Review, H1 2016’, provides an overview of the Idiopathic Pulmonary Fibrosis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Idiopathic Pulmonary Fibrosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Idiopathic Pulmonary Fibrosis and features dormant and discontinued projects. Global Markets D
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $2000
Relapsed Acute Myeloid Leukemia - Pipeline Review, H1 2016
Summary Global Markets Direct’s, ‘Relapsed Acute Myeloid Leukemia - Pipeline Review, H1 2016’, provides an overview of the Relapsed Acute Myeloid Leukemia pipeline landscape. The report provides comprehensive information on the therapeutics under development for Relapsed Acute Myeloid Leukemia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Relapsed Acute Myeloid Leukemia and features dormant and discontinued projects. Global M
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $2000
Clostridium difficile Infections (Clostridium difficile Associated Disease) - Pipeline Review, H1 2016
Summary Global Markets Direct’s, ‘Clostridium difficile Infections (Clostridium difficile Associated Disease) - Pipeline Review, H1 2016’, provides an overview of the Clostridium difficile Infections (Clostridium difficile Associated Disease) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Clostridium difficile Infections (Clostridium difficile Associated Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key player
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $2000
Acne Vulgaris - Pipeline Review, H1 2016
Summary Global Markets Direct’s, ‘Acne Vulgaris - Pipeline Review, H1 2016’, provides an overview of the Acne Vulgaris pipeline landscape. The report provides comprehensive information on the therapeutics under development for Acne Vulgaris, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Acne Vulgaris and features dormant and discontinued projects. Global Markets Direct’s report features investigational drugs from across glob
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $2000
Sickle Cell Disease - Pipeline Review, H1 2016
Summary Global Markets Direct’s, ‘Sickle Cell Disease - Pipeline Review, H1 2016’, provides an overview of the Sickle Cell Disease pipeline landscape. The report provides comprehensive information on the therapeutics under development for Sickle Cell Disease, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Sickle Cell Disease and features dormant and discontinued projects. Global Markets Direct’s report features investigationa
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $2000
Osteoarthritis Pain - Pipeline Review, H1 2016
Summary Global Markets Direct’s, ‘Osteoarthritis Pain - Pipeline Review, H1 2016’, provides an overview of the Osteoarthritis Pain pipeline landscape. The report provides comprehensive information on the therapeutics under development for Osteoarthritis Pain, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Osteoarthritis Pain and features dormant and discontinued projects. Global Markets Direct’s report features investigationa
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $2000
Chronic Urticaria Or Hives - Pipeline Review, H1 2016
Summary Global Markets Direct’s, ‘Chronic Urticaria Or Hives - Pipeline Review, H1 2016’, provides an overview of the Chronic Urticaria Or Hives pipeline landscape. The report provides comprehensive information on the therapeutics under development for Chronic Urticaria Or Hives, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Chronic Urticaria Or Hives and features dormant and discontinued projects. Global Markets Direct’s re
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $2000
Yellow Fever - Pipeline Review, H1 2016
Summary Global Markets Direct’s, ‘Yellow Fever - Pipeline Review, H1 2016’, provides an overview of the Yellow Fever pipeline landscape. The report provides comprehensive information on the therapeutics under development for Yellow Fever, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Yellow Fever and features dormant and discontinued projects. Global Markets Direct’s report features investigational drugs from across globe co
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $2000
Brain Ischemia - Pipeline Review, H1 2016
Summary Global Markets Direct’s, ‘Brain Ischemia - Pipeline Review, H1 2016’, provides an overview of the Brain Ischemia pipeline landscape. The report provides comprehensive information on the therapeutics under development for Brain Ischemia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Brain Ischemia and features dormant and discontinued projects. Global Markets Direct’s report features investigational drugs from across
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $2000
Measles - Pipeline Review, H1 2016
Summary Global Markets Direct’s, ‘Measles - Pipeline Review, H1 2016’, provides an overview of the Measles pipeline landscape. The report provides comprehensive information on the therapeutics under development for Measles, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Measles and features dormant and discontinued projects. Global Markets Direct’s report features investigational drugs from across globe covering over 20 thera
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $2000
Rotavirus Infections - Pipeline Review, H1 2016
Summary Global Markets Direct’s, ‘Rotavirus Infections - Pipeline Review, H1 2016’, provides an overview of the Rotavirus Infections pipeline landscape. The report provides comprehensive information on the therapeutics under development for Rotavirus Infections, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Rotavirus Infections and features dormant and discontinued projects. Global Markets Direct’s report features investigat
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $2000
Ageing - Pipeline Review, H1 2016
Summary Global Markets Direct’s, ‘Ageing - Pipeline Review, H1 2016’, provides an overview of the Ageing pipeline landscape. The report provides comprehensive information on the therapeutics under development for Ageing, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Ageing and features dormant and discontinued projects. Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy a
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $2000
Post Menopausal Osteoporosis - Pipeline Review, H1 2016
Summary Global Markets Direct’s, ‘Post Menopausal Osteoporosis - Pipeline Review, H1 2016’, provides an overview of the Post Menopausal Osteoporosis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Post Menopausal Osteoporosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Post Menopausal Osteoporosis and features dormant and discontinued projects. Global Markets Direc
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $2000
Basal Cell Carcinoma (Basal Cell Epithelioma) - Pipeline Review, H1 2016
Summary Global Markets Direct’s, ‘Basal Cell Carcinoma (Basal Cell Epithelioma) - Pipeline Review, H1 2016’, provides an overview of the Basal Cell Carcinoma (Basal Cell Epithelioma) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Basal Cell Carcinoma (Basal Cell Epithelioma), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Basal Cell Carcinoma (Basal Cell Epithelioma) an
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $2000
Allergic Conjunctivitis - Pipeline Review, H1 2016
Summary Global Markets Direct’s, ‘Allergic Conjunctivitis - Pipeline Review, H1 2016’, provides an overview of the Allergic Conjunctivitis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Allergic Conjunctivitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Allergic Conjunctivitis and features dormant and discontinued projects. Global Markets Direct’s report feature
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $2000
Angina (Angina Pectoris) - Pipeline Review, H1 2016
Summary Global Markets Direct’s, ‘Angina (Angina Pectoris) - Pipeline Review, H1 2016’, provides an overview of the Angina (Angina Pectoris) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Angina (Angina Pectoris), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Angina (Angina Pectoris) and features dormant and discontinued projects. Global Markets Direct’s report fea
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $2000
Equine Encephalitis - Pipeline Review, H1 2016
Summary Global Markets Direct’s, ‘Equine Encephalitis - Pipeline Review, H1 2016’, provides an overview of the Equine Encephalitis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Equine Encephalitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Equine Encephalitis and features dormant and discontinued projects. Global Markets Direct’s report features investigationa
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $2000
Narcolepsy - Pipeline Review, H1 2016
Summary Global Markets Direct’s, ‘Narcolepsy - Pipeline Review, H1 2016’, provides an overview of the Narcolepsy pipeline landscape. The report provides comprehensive information on the therapeutics under development for Narcolepsy, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Narcolepsy and features dormant and discontinued projects. Global Markets Direct’s report features investigational drugs from across globe covering o
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $2000
Epidermolysis Bullosa - Pipeline Review, H1 2016
Summary Global Markets Direct’s, ‘Epidermolysis Bullosa - Pipeline Review, H1 2016’, provides an overview of the Epidermolysis Bullosa pipeline landscape. The report provides comprehensive information on the therapeutics under development for Epidermolysis Bullosa, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Epidermolysis Bullosa and features dormant and discontinued projects. Global Markets Direct’s report features invest
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $2000
Hematopoietic Stem Cell Transplantation - Pipeline Review, H1 2016
Summary Global Markets Direct’s, ‘Hematopoietic Stem Cell Transplantation - Pipeline Review, H1 2016’, provides an overview of the Hematopoietic Stem Cell Transplantation pipeline landscape. The report provides comprehensive information on the therapeutics under development for Hematopoietic Stem Cell Transplantation, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Hematopoietic Stem Cell Transplantation and features dormant and d
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $2000
Keratitis - Pipeline Review, H1 2016
Summary Global Markets Direct’s, ‘Keratitis - Pipeline Review, H1 2016’, provides an overview of the Keratitis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Keratitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Keratitis and features dormant and discontinued projects. Global Markets Direct’s report features investigational drugs from across globe covering over
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $2000
Rosacea - Pipeline Review, H1 2016
Summary Global Markets Direct’s, ‘Rosacea - Pipeline Review, H1 2016’, provides an overview of the Rosacea pipeline landscape. The report provides comprehensive information on the therapeutics under development for Rosacea, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Rosacea and features dormant and discontinued projects. Global Markets Direct’s report features investigational drugs from across globe covering over 20 thera
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $2000
Febrile Neutropenia - Pipeline Review, H1 2016
Summary Global Markets Direct’s, ‘Febrile Neutropenia - Pipeline Review, H1 2016’, provides an overview of the Febrile Neutropenia pipeline landscape. The report provides comprehensive information on the therapeutics under development for Febrile Neutropenia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Febrile Neutropenia and features dormant and discontinued projects. Global Markets Direct’s report features investigationa
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $2000
Peanut Allergy - Pipeline Review, H1 2016
Summary Global Markets Direct’s, ‘Peanut Allergy - Pipeline Review, H1 2016’, provides an overview of the Peanut Allergy pipeline landscape. The report provides comprehensive information on the therapeutics under development for Peanut Allergy, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Peanut Allergy and features dormant and discontinued projects. Global Markets Direct’s report features investigational drugs from across
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $2000
Dementia Associated With Alzheimers Disease - Pipeline Review, H1 2016
Summary Global Markets Direct’s, ‘Dementia Associated With Alzheimer's Disease - Pipeline Review, H1 2016’, provides an overview of the Dementia Associated With Alzheimer's Disease pipeline landscape. The report provides comprehensive information on the therapeutics under development for Dementia Associated With Alzheimer's Disease, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Dementia Associated With Alzheimer's Disease and fe
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $2000
Peripheral Neuropathic Pain - Pipeline Review, H1 2016
Summary Global Markets Direct’s, ‘Peripheral Neuropathic Pain - Pipeline Review, H1 2016’, provides an overview of the Peripheral Neuropathic Pain pipeline landscape. The report provides comprehensive information on the therapeutics under development for Peripheral Neuropathic Pain, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Peripheral Neuropathic Pain and features dormant and discontinued projects. Global Markets Direct’
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $2000
Treatment Resistant Depression - Pipeline Review, H1 2016
Summary Global Markets Direct’s, ‘Treatment Resistant Depression - Pipeline Review, H1 2016’, provides an overview of the Treatment Resistant Depression pipeline landscape. The report provides comprehensive information on the therapeutics under development for Treatment Resistant Depression, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Treatment Resistant Depression and features dormant and discontinued projects. Global Marke
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $2000
Psychosis - Pipeline Review, H1 2016
Summary Global Markets Direct’s, ‘Psychosis - Pipeline Review, H1 2016’, provides an overview of the Psychosis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Psychosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Psychosis and features dormant and discontinued projects. Global Markets Direct’s report features investigational drugs from across globe covering over
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $2000
Vitiligo - Pipeline Review, H1 2016
Summary Global Markets Direct’s, ‘Vitiligo - Pipeline Review, H1 2016’, provides an overview of the Vitiligo pipeline landscape. The report provides comprehensive information on the therapeutics under development for Vitiligo, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Vitiligo and features dormant and discontinued projects. Global Markets Direct’s report features investigational drugs from across globe covering over 20 t
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $2000
Enterocolitis - Pipeline Review, H1 2016
Summary Global Markets Direct’s, ‘Enterocolitis - Pipeline Review, H1 2016’, provides an overview of the Enterocolitis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Enterocolitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Enterocolitis and features dormant and discontinued projects. Global Markets Direct’s report features investigational drugs from across glob
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $2000
Neurofibromatoses Type II - Pipeline Review, H1 2016
Summary Global Markets Direct’s, ‘Neurofibromatoses Type II - Pipeline Review, H1 2016’, provides an overview of the Neurofibromatoses Type II pipeline landscape. The report provides comprehensive information on the therapeutics under development for Neurofibromatoses Type II, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Neurofibromatoses Type II and features dormant and discontinued projects. Global Markets Direct’s report
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $2000
Essential Thrombocythemia - Pipeline Review, H1 2016
Summary Global Markets Direct’s, ‘Essential Thrombocythemia - Pipeline Review, H1 2016’, provides an overview of the Essential Thrombocythemia pipeline landscape. The report provides comprehensive information on the therapeutics under development for Essential Thrombocythemia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Essential Thrombocythemia and features dormant and discontinued projects. Global Markets Direct’s report
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $2000
Pheochromocytoma - Pipeline Review, H1 2016
Summary Global Markets Direct’s, ‘Pheochromocytoma - Pipeline Review, H1 2016’, provides an overview of the Pheochromocytoma pipeline landscape. The report provides comprehensive information on the therapeutics under development for Pheochromocytoma, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Pheochromocytoma and features dormant and discontinued projects. Global Markets Direct’s report features investigational drugs from
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $2000
Guillain-Barre Syndrome - Pipeline Review, H1 2016
Summary Global Markets Direct’s, ‘Guillain-Barre Syndrome - Pipeline Review, H1 2016’, provides an overview of the Guillain-Barre Syndrome pipeline landscape. The report provides comprehensive information on the therapeutics under development for Guillain-Barre Syndrome, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Guillain-Barre Syndrome and features dormant and discontinued projects. Global Markets Direct’s report feature
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $2000
Bronchiectasis - Pipeline Review, H1 2016
Summary Global Markets Direct’s, ‘Bronchiectasis - Pipeline Review, H1 2016’, provides an overview of the Bronchiectasis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Bronchiectasis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Bronchiectasis and features dormant and discontinued projects. Global Markets Direct’s report features investigational drugs from across
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $2000
CureVac GmbH - Product Pipeline Review - 2016
Summary Global Markets Direct’s, ‘CureVac GmbH - Product Pipeline Review - 2016’, provides an overview of the CureVac GmbH’s pharmaceutical research and development focus. The report provides comprehensive information on the therapeutics under development by CureVac GmbH, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects. Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from G
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $1500
Genmab A/S - Product Pipeline Review - 2016
Summary Global Markets Direct’s, ‘Genmab A/S - Product Pipeline Review - 2016’, provides an overview of the Genmab A/S’s pharmaceutical research and development focus. The report provides comprehensive information on the therapeutics under development by Genmab A/S, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects. Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $1500
INSYS Therapeutics, Inc. - Product Pipeline Review - 2016
Summary Global Markets Direct’s, ‘INSYS Therapeutics, Inc. - Product Pipeline Review - 2016’, provides an overview of the INSYS Therapeutics, Inc.’s pharmaceutical research and development focus. The report provides comprehensive information on the therapeutics under development by INSYS Therapeutics, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects. Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $1500
Orbis Biosciences, Inc. - Product Pipeline Review - 2016
Summary Global Markets Direct’s, ‘Orbis Biosciences, Inc. - Product Pipeline Review - 2016’, provides an overview of the Orbis Biosciences, Inc.’s pharmaceutical research and development focus. The report provides comprehensive information on the therapeutics under development by Orbis Biosciences, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects. Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using da
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $1500
Spectrum Pharmaceuticals, Inc. - Product Pipeline Review - 2016
Summary Global Markets Direct’s, ‘Spectrum Pharmaceuticals, Inc. - Product Pipeline Review - 2016’, provides an overview of the Spectrum Pharmaceuticals, Inc.’s pharmaceutical research and development focus. The report provides comprehensive information on the therapeutics under development by Spectrum Pharmaceuticals, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects. Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The rep
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $1500
UCB S.A. - Product Pipeline Review - 2016
Summary Global Markets Direct’s, ‘UCB S.A. - Product Pipeline Review - 2016’, provides an overview of the UCB S.A.’s pharmaceutical research and development focus. The report provides comprehensive information on the therapeutics under development by UCB S.A., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects. Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Market
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $1500
Zealand Pharma A/S - Product Pipeline Review - 2016
Summary Global Markets Direct’s, ‘Zealand Pharma A/S - Product Pipeline Review - 2016’, provides an overview of the Zealand Pharma A/S’s pharmaceutical research and development focus. The report provides comprehensive information on the therapeutics under development by Zealand Pharma A/S, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects. Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and informat
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $1500
Hepatitis C - Pipeline Review, H1 2016
Summary Global Markets Direct’s, ‘Hepatitis C - Pipeline Review, H1 2016’, provides an overview of the Hepatitis C pipeline landscape. The report provides comprehensive information on the therapeutics under development for Hepatitis C, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Hepatitis C and features dormant and discontinued projects. Global Markets Direct’s report features investigational drugs from across globe coveri
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $2000
Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H1 2016
Summary Global Markets Direct’s, ‘Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H1 2016’, provides an overview of the Chronic Obstructive Pulmonary Disease (COPD) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Chronic Obstructive Pulmonary Disease (COPD), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Chronic Obstructive Pulmonary Disease (COPD) and fe
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $2000
Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H1 2016
Summary Global Markets Direct’s, ‘Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H1 2016’, provides an overview of the Plaque Psoriasis (Psoriasis Vulgaris) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Plaque Psoriasis (Psoriasis Vulgaris), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Plaque Psoriasis (Psoriasis Vulgaris) and features dormant and discontin
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $2000
H1N1 Infection - Pipeline Review, H1 2016
Summary Global Markets Direct’s, ‘H1N1 Infection - Pipeline Review, H1 2016’, provides an overview of the H1N1 Infection pipeline landscape. The report provides comprehensive information on the therapeutics under development for H1N1 Infection, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for H1N1 Infection and features dormant and discontinued projects. Global Markets Direct’s report features investigational drugs from across
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $2000
Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2016
Summary Global Markets Direct’s, ‘Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2016’, provides an overview of the Recurrent Glioblastoma Multiforme (GBM) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Recurrent Glioblastoma Multiforme (GBM), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Recurrent Glioblastoma Multiforme (GBM) and features dormant and d
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $2000
Major Depressive Disorder - Pipeline Review, H1 2016
Summary Global Markets Direct’s, ‘Major Depressive Disorder - Pipeline Review, H1 2016’, provides an overview of the Major Depressive Disorder pipeline landscape. The report provides comprehensive information on the therapeutics under development for Major Depressive Disorder, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Major Depressive Disorder and features dormant and discontinued projects. Global Markets Direct’s report
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $2000
Uveitis - Pipeline Review, H1 2016
Summary Global Markets Direct’s, ‘Uveitis - Pipeline Review, H1 2016’, provides an overview of the Uveitis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Uveitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Uveitis and features dormant and discontinued projects. Global Markets Direct’s report features investigational drugs from across globe covering over 20 thera
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $2000
Chronic Kidney Disease (Chronic Renal Failure) - Pipeline Review, H1 2016
Summary Global Markets Direct’s, ‘Chronic Kidney Disease (Chronic Renal Failure) - Pipeline Review, H1 2016’, provides an overview of the Chronic Kidney Disease (Chronic Renal Failure) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Chronic Kidney Disease (Chronic Renal Failure), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Chronic Kidney Disease (Chronic Renal Failure
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $2000
Acinetobacter Infections - Pipeline Review, H1 2016
Summary Global Markets Direct’s, ‘Acinetobacter Infections - Pipeline Review, H1 2016’, provides an overview of the Acinetobacter Infections pipeline landscape. The report provides comprehensive information on the therapeutics under development for Acinetobacter Infections, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Acinetobacter Infections and features dormant and discontinued projects. Global Markets Direct’s report fea
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $2000
Klebsiella pneumoniae Infections - Pipeline Review, H1 2016
Summary Global Markets Direct’s, ‘Klebsiella pneumoniae Infections - Pipeline Review, H1 2016’, provides an overview of the Klebsiella pneumoniae Infections pipeline landscape. The report provides comprehensive information on the therapeutics under development for Klebsiella pneumoniae Infections, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Klebsiella pneumoniae Infections and features dormant and discontinued projects. Glob
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $2000
Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H1 2016
Summary Global Markets Direct’s, ‘Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H1 2016’, provides an overview of the Relapsing Remitting Multiple Sclerosis (RRMS) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Relapsing Remitting Multiple Sclerosis (RRMS), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Relapsing Remitting Multiple Sclerosis (RRMS) an
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $2000
Kidney Transplantation - Pipeline Review, H1 2016
Summary Global Markets Direct’s, ‘Kidney Transplantation - Pipeline Review, H1 2016’, provides an overview of the Kidney Transplantation pipeline landscape. The report provides comprehensive information on the therapeutics under development for Kidney Transplantation, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Kidney Transplantation and features dormant and discontinued projects. Global Markets Direct’s report features in
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $2000
Bone Metastasis - Pipeline Review, H1 2016
Summary Global Markets Direct’s, ‘Bone Metastasis - Pipeline Review, H1 2016’, provides an overview of the Bone Metastasis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Bone Metastasis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Bone Metastasis and features dormant and discontinued projects. Global Markets Direct’s report features investigational drugs from acr
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $2000
Kidney Fibrosis - Pipeline Review, H1 2016
Summary Global Markets Direct’s, ‘Kidney Fibrosis - Pipeline Review, H1 2016’, provides an overview of the Kidney Fibrosis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Kidney Fibrosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Kidney Fibrosis and features dormant and discontinued projects. Global Markets Direct’s report features investigational drugs from acr
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $2000
Overactive Bladder - Pipeline Review, H1 2016
Summary Global Markets Direct’s, ‘Overactive Bladder - Pipeline Review, H1 2016’, provides an overview of the Overactive Bladder pipeline landscape. The report provides comprehensive information on the therapeutics under development for Overactive Bladder, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Overactive Bladder and features dormant and discontinued projects. Global Markets Direct’s report features investigational dr
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $2000
Neisseria meningitidis Infections - Pipeline Review, H1 2016
Summary Global Markets Direct’s, ‘Neisseria meningitidis Infections - Pipeline Review, H1 2016’, provides an overview of the Neisseria meningitidis Infections pipeline landscape. The report provides comprehensive information on the therapeutics under development for Neisseria meningitidis Infections, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Neisseria meningitidis Infections and features dormant and discontinued projects.
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $2000
Chagas Disease (American Trypanosomiasis) - Pipeline Review, H1 2016
Summary Global Markets Direct’s, ‘Chagas Disease (American Trypanosomiasis) - Pipeline Review, H1 2016’, provides an overview of the Chagas Disease (American Trypanosomiasis) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Chagas Disease (American Trypanosomiasis), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Chagas Disease (American Trypanosomiasis) and features dorma
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $2000
Chronic Heart Failure - Pipeline Review, H1 2016
Summary Global Markets Direct’s, ‘Chronic Heart Failure - Pipeline Review, H1 2016’, provides an overview of the Chronic Heart Failure pipeline landscape. The report provides comprehensive information on the therapeutics under development for Chronic Heart Failure, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Chronic Heart Failure and features dormant and discontinued projects. Global Markets Direct’s report features invest
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $2000
Waldenstrom Macroglobulinemia - Pipeline Review, H1 2016
Summary Global Markets Direct’s, ‘Waldenstrom Macroglobulinemia - Pipeline Review, H1 2016’, provides an overview of the Waldenstrom Macroglobulinemia pipeline landscape. The report provides comprehensive information on the therapeutics under development for Waldenstrom Macroglobulinemia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Waldenstrom Macroglobulinemia and features dormant and discontinued projects. Global Markets D
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $2000
Mild Cognitive Impairment - Pipeline Review, H1 2016
Summary Global Markets Direct’s, ‘Mild Cognitive Impairment - Pipeline Review, H1 2016’, provides an overview of the Mild Cognitive Impairment pipeline landscape. The report provides comprehensive information on the therapeutics under development for Mild Cognitive Impairment, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Mild Cognitive Impairment and features dormant and discontinued projects. Global Markets Direct’s report
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $2000
Hemophilia B - Pipeline Review, H1 2016
Summary Global Markets Direct’s, ‘Hemophilia B - Pipeline Review, H1 2016’, provides an overview of the Hemophilia B pipeline landscape. The report provides comprehensive information on the therapeutics under development for Hemophilia B, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Hemophilia B and features dormant and discontinued projects. Global Markets Direct’s report features investigational drugs from across globe co
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $2000
Chikungunya - Pipeline Review, H1 2016
Summary Global Markets Direct’s, ‘Chikungunya - Pipeline Review, H1 2016’, provides an overview of the Chikungunya pipeline landscape. The report provides comprehensive information on the therapeutics under development for Chikungunya, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Chikungunya and features dormant and discontinued projects. Global Markets Direct’s report features investigational drugs from across globe coveri
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $2000
Pancreatic Ductal Adenocarcinoma - Pipeline Review, H1 2016
Summary Global Markets Direct’s, ‘Pancreatic Ductal Adenocarcinoma - Pipeline Review, H1 2016’, provides an overview of the Pancreatic Ductal Adenocarcinoma pipeline landscape. The report provides comprehensive information on the therapeutics under development for Pancreatic Ductal Adenocarcinoma, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Pancreatic Ductal Adenocarcinoma and features dormant and discontinued projects. Glob
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $2000
Rabies - Pipeline Review, H1 2016
Summary Global Markets Direct’s, ‘Rabies - Pipeline Review, H1 2016’, provides an overview of the Rabies pipeline landscape. The report provides comprehensive information on the therapeutics under development for Rabies, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Rabies and features dormant and discontinued projects. Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy a
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $2000
Celiac Disease - Pipeline Review, H1 2016
Summary Global Markets Direct’s, ‘Celiac Disease - Pipeline Review, H1 2016’, provides an overview of the Celiac Disease pipeline landscape. The report provides comprehensive information on the therapeutics under development for Celiac Disease, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Celiac Disease and features dormant and discontinued projects. Global Markets Direct’s report features investigational drugs from across
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $2000
Shigella Infections (Shigellosis) - Pipeline Review, H1 2016
Summary Global Markets Direct’s, ‘Shigella Infections (Shigellosis) - Pipeline Review, H1 2016’, provides an overview of the Shigella Infections (Shigellosis) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Shigella Infections (Shigellosis), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Shigella Infections (Shigellosis) and features dormant and discontinued projects.
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $2000
Metastatic Ovarian Cancer - Pipeline Review, H1 2016
Summary Global Markets Direct’s, ‘Metastatic Ovarian Cancer - Pipeline Review, H1 2016’, provides an overview of the Metastatic Ovarian Cancer pipeline landscape. The report provides comprehensive information on the therapeutics under development for Metastatic Ovarian Cancer, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Metastatic Ovarian Cancer and features dormant and discontinued projects. Global Markets Direct’s report
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $2000
Japanese Encephalitis - Pipeline Review, H1 2016
Summary Global Markets Direct’s, ‘Japanese Encephalitis - Pipeline Review, H1 2016’, provides an overview of the Japanese Encephalitis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Japanese Encephalitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Japanese Encephalitis and features dormant and discontinued projects. Global Markets Direct’s report features invest
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $2000
Contact Dermatitis - Pipeline Review, H1 2016
Summary Global Markets Direct’s, ‘Contact Dermatitis - Pipeline Review, H1 2016’, provides an overview of the Contact Dermatitis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Contact Dermatitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Contact Dermatitis and features dormant and discontinued projects. Global Markets Direct’s report features investigational dr
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $2000
Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) Type C - Pipeline Review, H1 2016
Summary Global Markets Direct’s, ‘Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) Type C - Pipeline Review, H1 2016’, provides an overview of the Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) Type C pipeline landscape. The report provides comprehensive information on the therapeutics under development for Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) Type C, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development f
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $2000
Hepatitis D - Pipeline Review, H1 2016
Summary Global Markets Direct’s, ‘Hepatitis D - Pipeline Review, H1 2016’, provides an overview of the Hepatitis D pipeline landscape. The report provides comprehensive information on the therapeutics under development for Hepatitis D, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Hepatitis D and features dormant and discontinued projects. Global Markets Direct’s report features investigational drugs from across globe coveri
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $2000
Axillary Hyperhidrosis - Pipeline Review, H1 2016
Summary Global Markets Direct’s, ‘Axillary Hyperhidrosis - Pipeline Review, H1 2016’, provides an overview of the Axillary Hyperhidrosis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Axillary Hyperhidrosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Axillary Hyperhidrosis and features dormant and discontinued projects. Global Markets Direct’s report features in
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $2000
Eosinophilic Esophagitis - Pipeline Review, H1 2016
Summary Global Markets Direct’s, ‘Eosinophilic Esophagitis - Pipeline Review, H1 2016’, provides an overview of the Eosinophilic Esophagitis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Eosinophilic Esophagitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Eosinophilic Esophagitis and features dormant and discontinued projects. Global Markets Direct’s report fea
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $2000
Gastroenteritis - Pipeline Review, H1 2016
Summary Global Markets Direct’s, ‘Gastroenteritis - Pipeline Review, H1 2016’, provides an overview of the Gastroenteritis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Gastroenteritis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Gastroenteritis and features dormant and discontinued projects. Global Markets Direct’s report features investigational drugs from acr
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $2000
Thrombotic Thrombocytopenic Purpura - Pipeline Review, H1 2016
Summary Global Markets Direct’s, ‘Thrombotic Thrombocytopenic Purpura - Pipeline Review, H1 2016’, provides an overview of the Thrombotic Thrombocytopenic Purpura pipeline landscape. The report provides comprehensive information on the therapeutics under development for Thrombotic Thrombocytopenic Purpura, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Thrombotic Thrombocytopenic Purpura and features dormant and discontinued proj
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $2000
Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Pipeline Review, H1 2016
Summary Global Markets Direct’s, ‘Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Pipeline Review, H1 2016’, provides an overview of the Adrenocortical Carcinoma (Adrenal Cortex Cancer) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Adrenocortical Carcinoma (Adrenal Cortex Cancer), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Adrenocortical Carcinoma (Adrenal Corte
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $2000
Dystonia - Pipeline Review, H1 2016
Summary Global Markets Direct’s, ‘Dystonia - Pipeline Review, H1 2016’, provides an overview of the Dystonia pipeline landscape. The report provides comprehensive information on the therapeutics under development for Dystonia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Dystonia and features dormant and discontinued projects. Global Markets Direct’s report features investigational drugs from across globe covering over 20 t
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $2000
Leber Congenital Amaurosis (LCA) - Pipeline Review, H1 2016
Summary Global Markets Direct’s, ‘Leber Congenital Amaurosis (LCA) - Pipeline Review, H1 2016’, provides an overview of the Leber Congenital Amaurosis (LCA) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Leber Congenital Amaurosis (LCA), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Leber Congenital Amaurosis (LCA) and features dormant and discontinued projects. Glob
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $2000